Summary
Background Presence of cerebral microbleeds (CMB) on MRI brain, increases risk of intracerebral haemorrhage in patients with atrial fibrillation (AF) who require anticoagulation. The retina shares similar embryological and pathological properties with cerebral vessels. Studying changes in retinal vasculature at capillary level associated with presence of CMB may provide complementary prognostic information to assess risk of anticoagulant-related intracerebral hemorrhage.
We aimed to investigate changes in the retinal capillary network associated with presence of CMB in patients with AF using Optical Coherence Tomography-Angiography (OCT-A).
Methods Patients with AF were prospectively recruited to undergo both OCT-A and MRI brain. OCT-A metrics of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) at macular region, along with the radial peripapillary capillary network at disc center were measured quantitatively by an automated image analysis program. Multivariable logistic regression and quasi-poisson regression were performed to investigate the association of OCT-A metrics with presence and burden of CMBs respectively. Significant OCT-A metrics were compared between patients with AF and healthy control subjects.
Results Among 99 patients with AF, 29 patients had CMB. A larger foveal avascular zone (FAZ) in SCP, also higher vessel diameter index (VDI) across SCP, DCP and disc center were significantly associated with presence and burden of CMB, after adjusting for age, diabetes mellitus, white matter hyperintensities ratio, image quality index, age, duration between OCT-A and MRI. A lower vessel density in SCP was associated with presence but not burden of CMB. Compared with healthy control, FAZ and VDI across SCP, DCP and disc area remained consistently different between patients with AF and control group.
Conclusions This pilot study provides preliminary data supporting potential role of OCT-A to assist risk-stratification of bleeding-prone microangiopathy for patients with AF who require anticoagulation. Further studies with larger sample size and different ethnic groups are needed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was supported by the Health and Medical Research Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (Ref. No. 2018.345)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Annqonymized data of this study will be available from Corresponding Author upon justified request.
